The incidence of UTUC in congenital pelvic kidneys is not statistically different from the kidneys located in the true retroperitoneum with very few reported cases. The incidence of UTUC in transplanted kidneys depends on the pre-existing risks of the donor and those acquired by the recipient. The majority of these cases are reported from the Balkan region and Southeast Asia due to consumption of aristolochic acid. We will review the current available literature data in this chapter.
Upper tract urothelial cell carcinoma (UTUC) Urothelial cell carcinoma (UC) Renal transplant Pelvic kidney Autotransplant kidney De novo malignancies in end stage renal disease (ESRD) De novo malignancies in renal transplant recipients Aristolochic acid
This is a preview of subscription content, log in to check access.
Kauffman HM, et al. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int. 2006;19(8):607–20.CrossRefPubMedGoogle Scholar
Chuang FR, et al. Increasing transplant cancer patient survival by conversion of immunosuppressive agents (0041–1345 (Print)).Google Scholar
Zhang A, et al. A retrospective review of patients with urothelial cancer in 3370 recipients after renal transplantation: a single-center experience. World J Urol. 2015;33(5):713–7.CrossRefPubMedGoogle Scholar
Lai MK, Tai HC, Wang SM. Urothelial carcinoma in renal transplant recipients. In: Trzcinska M, editor. Kidney transplantation—new perspectives. InTech; 2011.Google Scholar
Hevia V, et al. Transitional cell carcinoma of the kidney graft: an extremely uncommon presentation of tumor in renal transplant recipients. Case Rep Transplant. 2013;2013:196528.PubMedPubMedCentralGoogle Scholar
Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355(9218):1886–7.CrossRefPubMedGoogle Scholar
Stewart JH, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14(1):197–207.CrossRefPubMedGoogle Scholar